Monte Rosa Therapeutics

Monte Rosa Therapeutics

Monte Rosa Therapeutics

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Founded
2018
Raised
$32.5M
Follow us
Latest funding
$32,500,000
Venture capital (Series A) - 2020
Versant Ventures New Enterprise Associates
Team Size
1–10
Employees
$32,500,000 Venture capital (Series A)
FinSMEs

Monte Rosa Therapeutics Raises $32.5M Financing